CSL Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

Date: January 15, 2017
Pages: 50
US$ 499.00
CSL Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Publisher: BAC Reports
Report type: Strategic Report
Delivery: E-mail Delivery - PDF (on default),
Hard Copy Mail Delivery (+US$ 190.00)
ID: C3303996B9FBEN

Download PDF Leaflet

CSL Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
CSL Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between CSL Ltd. and its competitors. This provides our Clients with a clear understanding of CSL Ltd. position in the Pharmaceuticals and Biotechnology Industry.

  • The report contains detailed information about CSL Ltd. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
  • Another part of the report is a SWOT-analysis carried out for CSL Ltd.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
  • The CSL Ltd. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
  • In the part that describes CSL Ltd. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
  • Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of CSL Ltd. business.

About CSL Ltd.

CSL Limited is a public company which is a parent company of the CSL Group. CSL business activities are carried out through its Human Health, JRH Biosciences, Animal Health and ZLB Plasma Services operations. CSL limited develops, manufactures and markets pharmaceutical products of biological origin. The company’s business is health care: Life-saving products derived from human plasma; Pharmaceuticals and diagnostics essential to health; Cell culture reagents for the pharmaceutical industry; and Veterinary vaccines and diagnostics to protect livestock and companion animals. The company’s Human Health business includes the operations of ZLB Bioplasma, CSL Bioplasma, CSL Pharmaceutical, and its global new product development activities.

JRH Biosciences Pty, Ltd, based in Melbourne, is a subsidiary of CSL Limited that processes Australian animal serum used to produce cell culture media.

CSL (New Zealand) Limited, based in Auckland, is a subsidiary of CSL Limited and is the New Zealand marketing arm for Australian Bioplasma, Pharmaceutical and Animal Health business operations. CSL (New Zealand) Limited also manufactures veterinary viral vaccines at a plant in Upper Hutt, near Wellington.

Iscotec AB, a Swedish company, is a subsidiary of CSL Limited that has technology to enhance the immune response to vaccines.

Cervax Pty, Ltd is a subsidiary of CSL Limited and is a company formed to undertake a specific research and development project. Cervax is 74% owned by CSL.

CSL International Pty, Ltd is a subsidiary of CSL Limited and the holding company for the international operations of the CSL Group.

CSL Denmark ApS is a subsidiary of CSL International Pty Ltd and the holding company for the European subsidiaries of the Group.

CSL US, Inc. is a subsidiary of CSL International Pty Ltd and the holding company for the US operations of the CSL Group.

CSL Finance Pty, Ltd is a subsidiary of CSL International Pty Ltd through which the CSL Group raises debt funding.

JRH Biosciences, Inc. is a subsidiary of CSL US, Inc. Based in Kansas in the US, it is one of the manufacturers of specialised cell culture media in the world. JRH Biosciences, Inc. has manufacturing sites in Kansas and Pennsylvania.

Biocor Animal Health Inc. is a subsidiary of CSL US, Inc. Based in the US at Omaha in Nebraska, Biocor manufactures and markets veterinary vaccines and is operationally part of CSL's Animal Health Group.

ZLB Bioplasma, Inc., a Los Angeles based subsidiary of CSL US, Inc., is operationally part of ZLB Bioplasma AG. In the US, ZLB Bioplasma, Inc. markets and distributes plasma-derived products and operates ZLB Plasma Services, a Florida based plasma collection business.

ZLB Bioplasma AG., based in Bern, Switzerland, is a subsidiary of CSL Denmark ApS. ZLB Bioplasma AG manufactures plasmaderived products and has major markets in the US and Europe.

ZLB Bioplasma Belgium sprl, a subsidiary of CSL Denmark ApS, is a sales and marketing company for plasma products manufactured by ZLB Bioplasma AG.

ZLB Bioplasma Italy srl, a subsidiary of CSL Denmark ApS, is a sales and marketing company for plasma products manufactured by ZLB Bioplasma AG.

CSL UK Holdings Limited, a subsidiary of CSL Denmark ApS, is the holding company for the United Kingdom operations of the CSL Group.

JRH Biosciences Limited, based in Andover in the United Kingdom, is a subsidiary of CSL UK Holdings Limited and is the European sales and marketing arm of JRH Biosciences Inc.

ZLB Bioplasma UK Limited, a subsidiary of CSL UK Holdings Limited, is a sales and marketing company for plasma products manufactured by ZLB Bioplasma AG.

ZLB GmbH, a German subsidiary of ZLB Bioplasma AG, is a sales and marketing company for plasma products manufactured by ZLB Bioplasma AG.

ZLB Bioplasma AG, based at Bern in Switzerland, is one of the manufacturers of plasma products in the world with major markets in the USA and Europe. Major plasma products marketed by zlb bioplasma are Carimune NF, Carimune, Redimune, Sandoglobulin, Panglobulin, Rhophylac and Albumin.

CSL Bioplasma is one of the manufacturers of plasma products in the Southern Hemispher

The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.




1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History


2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units


3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats


4.1. Financial Statements
  4.1.1. Income Statement
  4.1.2. Balance Sheet
  4.1.3. Cash Flow
4.2. Financial Ratios
  4.2.1. Profitability
  4.2.2. Margin Analysis
  4.2.3. Asset Turnover
  4.2.4. Credit Ratios
  4.2.5. Long-Term Solvency
  4.2.6. Growth Over Prior Year
  4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot


5.1. CSL Ltd. Direct Competitors
5.2. Comparison of CSL Ltd. and Direct Competitors Financial Ratios
5.3. Comparison of CSL Ltd. and Direct Competitors Stock Charts
5.4. CSL Ltd. Industry Analysis
  5.4.1. Pharmaceuticals and Biotechnology Industry Snapshot
  5.4.2. CSL Ltd. Industry Position Analysis


6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events


7.1. Experts Opinion
7.2. Experts Estimates



9.1. Political Factors
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors


10.1. Internal Factor Evaluation Matrix
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix





CSL Ltd. Key Facts
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
CSL Ltd. Key Executives
Key Executives Biographies1
Key Executives Compensations1
CSL Ltd. Major Shareholders
CSL Ltd. History
CSL Ltd. Products
Revenues by Segment
Revenues by Region
CSL Ltd. Offices and Representations
CSL Ltd. SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
CSL Ltd. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
CSL Ltd. Capital Market Snapshot
CSL Ltd. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Pharmaceuticals and Biotechnology Industry Statistics
CSL Ltd. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
CSL Ltd. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Historical Surprises1
Revenue Estimates Trend1
Earnings Estimates Trend1
Revenue Revisions1


CSL Ltd. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
CSL Ltd. 1-year Stock Charts
CSL Ltd. 5-year Stock Charts
CSL Ltd. vs. Main Indexes 1-year Stock Chart
CSL Ltd. vs. Direct Competitors 1-year Stock Charts
CSL Ltd. Article Density Chart

1 – Data availability depends on company’s security policy.
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.

Enhanced SWOT Analysis

Enhanced SWOT is a 3×3 grid that arranges strengths, weaknesses, opportunities and threats into one scheme:

  • How to use the strengths to take advantage of the opportunities?
  • How to use the strengths to reduce likelihood and impact of the threats?
  • How to overcome the weaknesses that obstruct taking advantage of the opportunities?
  • How to overcome the weaknesses that can make the threats a reality?

Upon answering these questions a company can develop a project plan to improve its business performance.

PESTEL Analysis

PESTEL (also termed as PESTLE) is an ideal tool to strategically analyze what influence different outside factors – political, economic, sociocultural, technological, environmental and legal – exert on a business to later chart its long term targets.

Being part of the external analysis when carrying out a strategic assessment or performing a market study, PESTEL gives an overview of diverse macro-environmental factors that any company should thoughtfully consider. By perceiving these outside environments, businesses can maximally benefit from the opportunities while minimizing the threats to the organization.

Key Factors Examined by PESTEL Analysis:

  • Political – What opportunities and pressures are brought by political bodies and what is the degree of public regulations’ impact on the business?
  • Economic – What economic policies, trends and structures are expected to affect the organization, what is this influence’s degree?
  • Sociological – What cultural and societal aspects will work upon the demand for the business’s products and operations?
  • Technological – What impact do the technological aspects, innovations, incentives and barriers have on the organization?
  • Environmental – What environmental and ecological facets, both locally and farther afield, are likely to predetermine the business?
  • Legal – What laws and legislation will exert influence on the style the business is carried out?

IFE, EFE, IE Matrices

The Internal Factor Evaluation matrix (IFE matrix) is a strategic management tool helping audit or evaluate major weaknesses and strengths in a business’s functional areas. In addition, IFE matrix serves as a basis for identifying and assessing relationships amongst those areas. The IFE matrix is utilised in strategy formulation.

The External Factor Evaluation matrix (EFE matrix) is a tool of strategic management that is typically utilised to assess current market conditions. It is an ideal instrument for visualising and prioritising the threats and opportunities a firm is facing.

The essential difference between the above mentioned matrices lies in the type of factors incorporated in the model; whilst the latter is engaged in internal factors, the former deals exceptionally with external factors – those exposed to social, political, economic, legal, etc. external forces.

Being a continuation of the EFE matrix and IFE matrix models, the Internal External matrix (IE matrix) rests upon an investigation of external and internal business factors integrated into one suggestive model.

Porter Five Forces Analysis

The Porter’s five forces analysis studies the industry of operation and helps the company find new sources of competitive advantage. The analysis surveys an industry through five major questions:

  1. What composes a threat of substitute products and services?
  2. Is there a threat of new competitors entering the market?
  3. What is the intensity of competitive rivalry?
  4. How big is the bargaining power of buyers?
  5. How significant is the bargaining power of suppliers?

VRIO Analysis

VRIO stands for Value, Rarity, Imitability, Organization. This analysis helps to evaluate all company’s resources and capabilities and bring them together into one aggregate table that includes:

  • Tangible resources
    • Financial
    • Physical
    • Technological
    • Organizational
  • Intangible resources
    • Human
    • Innovation and Creativity
    • Reputation
  • Organizational capabilities

The result of the analysis gives a clear picture of company’s competitive and economic implications, answering the questions if the resources mentioned above are:

  • Valuable?
  • Rare?
  • Costly to imitate?
  • Organized properly?
Skip to top

CSL business profile (company report) US$ 99.00 Aug, 2011 · 30 pages

Ask Your Question

CSL Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: